StockNews.AI
FNA
StockNews.AI
194 days

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AZPN, LRFC, ALVR on Behalf of Shareholders

1. Paragon 28 is being sold to Zimmer Biomet for $13.00 per share. 2. Shareholders may receive an additional $1.00 per share based on revenue milestones. 3. Halper Sadeh LLC is investigating potential shareholder rights violations. 4. The investigation may influence shareholder satisfaction and transaction value. 5. Legal discussions are ongoing to enhance shareholder protections and disclosures.

4m saved
Insight
Article

FAQ

Why Neutral?

The sale price aligns with market expectations but potential legal issues could affect demand.

How important is it?

The outcome of the investigation could affect Paragon 28's perceived value to investors.

Why Short Term?

Immediate investigations may lead to action, impacting short-term shareholder sentiment.

Related Companies

FNAZBH
NEW YORK, Feb. 6, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Paragon 28, Inc. (NYSE: FNA)'s sale to Zimmer Biomet Holdings, Inc. for $13.00 per share in cash. Paragon 28 shareholders will also receive a non-tradeable contingent value right entitling the holder to receive up to $1.00 per share in cash if certain revenue milestones are achieved. If you are a Paragon 28 shareholder, click here to learn more about your rights and options. Aspen Technology, Inc. (NASDAQ: AZPN)'s sale to Emerson for $265.00 per share in cash. If you are an Aspen shareholder, click here to learn more about your rights and options. Logan Ridge Finance Corporation (NASDAQ: LRFC)'s sale to Portman Ridge Finance Corporation for 1.50 newly issued shares of Portman common stock in exchange for each share of common stock of Logan Ridge. If you are a Logan Ridge shareholder, click here to learn more about your rights and options. AlloVir, Inc. (NASDAQ: ALVR)'s merger with Kalaris Therapeutics. If you are an AlloVir shareholder, click here to learn more about your rights and options. Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected]. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information:Halper Sadeh LLCDaniel Sadeh, Esq.Zachary Halper, Esq.(212) 763-0060[email protected][email protected] https://www.halpersadeh.com SOURCE Halper Sadeh LLP

Related News